BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): A mutation analyses

Breast Cancer Research and Treatment

Volumn 105, Issue 3, 2007, Pages 267-276

  Russo, Antonio ^a   Calò, Valentina ^a   Agnese, Valentina ^a   Bruno, Loredana ^a   Corsale, Simona ^a   Augello, Claudia ^a   Gargano, Grazia ^a   Barbera, Floriana ^a   Cascio, Sandra ^a   Intrivici, Chiara ^a   Rinaldi, Gaetana ^a   Gulotta, Gaspare ^a   Macaluso, Marcella ^b   Surmacz, Eva ^b   Giordano, Antonio ^b   Gebbia, Nicola ^a   Bazan, Viviana ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Temple University   (United States)

Author keywords

BRCA1; Breast cancer; Genetic testing; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; ITALY; MUTATIONAL ANALYSIS; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; AGED; BASE SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 35348971357     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9456-9     Document Type: Article

References (50)

1. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
2. Ford D, Easton DF, Stratton M et al and Breast Cancer linkage Consortium (1998) Genetic heterogenicity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689
3. Pharoah PD, Antoniou A, Bobrow M et al (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31:33-36
4. Callebaut I, Mornon JP. (1997) From BRCA1 to Rap1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 400(1):25-30
5. Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identifìed in a risk evaluation program. J Natl Cancer Inst 9418:1365-1372
6. Ford D, Easton DF, Bishop DT et al (1994) Breast Cancer Linkage Consortium. Lancet 343:692-695
7. Lynch HT, Watson P, Narod SA (1999) The genetic epidemiology of male breast carcinoma. Cancer 86(5):744-746
8. Nkondjock A, Ghadirian P. (2004) Epidemiology of breast cancer among BRCA mutation carriers: an overview. Cancer Lett 2051:1-8
9. Takahashi H, Behbakht K, McGovern PE et al (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998-3002
10. Easton DF, Hopper JL, Thomas DC et al (2004) Breast cancer risks for BRCA1/2 carriers. Science 306:2187-2188
11. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130
12. Marroni F, Aretini P, D'Andrea E et al (2004 )Penetrance of breast ad ovarian cancer in a large series of families tested for BRCA1/2 mutations. Eur J Hum Genet 12:899-906
13. Cipollini G, Tommasi S, Paradiso A et al (2004) Genetic alteration in hereditary breast cancer. Ann Oncol 15:7-13
14. Szabo CI, King MC. (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020
15. Peelen T, van Vliet M, Petrij-Bosch A et al (1997). A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041-1049
16. Einbeigi Z, Bergman A, Kindblom LG et al (2001) A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 37:1904-1909
17. Pisano M, Cossu A, Persico I et al (2000) Identification of a founder BRCA2 mutation in Sardinia. Br J Cancer 82:553-559
18. Baudi F, Quaresima B, Grandinetti C et al (2001)Evidence of a founder mutation of BRCA1 gene in a highly homogeneous population from southern Italy with breast/ ovarian cancer. Hum Mut 18:163-164
19. Breast Cancer Information Core (BIC) (2002) An open access on line breast cancer mutation database. Retrived from http://www.hhgri.nih.gov/ Intramural_transfer/Bic/
20. Judkins T, Hendrickson BC, Deffenbaugh MA et al (2005) Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mut Res 573:168-179
21. Goldgard DE, Easton DF, Deffenbaugh AM et al (2004) Breast Cancer Information Core (BIC) Sterring Committee. Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535-544
22. Phelan CM, Dapic V, Tice B et al (2004) Classification of BRCA1 missense variants of unknown clinical significance. Am J Hum Genet 75:535-544
23. ASCO (1996) Statement of the American Society of Clinical Oncology, genetic testing for cancer susceptibility, Adopted on Febbruary 20, 1996. J Clin Oncol 14:1730-1740
24. ASCO (2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:2397-2406
25. Friedman LS, Ostermeyer EA, Szabo CI et al (1994) Confirmation of BRCA 1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399-404
26. Caligo MA, Ghimenti C, Cipollini G et al (1996) BRCA1 germline mutation spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene 13:1483-1488.
27. Antonarakis SE. (1998) Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat 11(1):1-3
28. Augello C, Gregorio V, Bazan V et al (2006) TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. J Cell Physiol Jun 207(3):654-659
29. Ottini L, D'Amico C, Noviello C et al (2000) BRCA1 and BRCA2 mutations in central and southern Italian patients. Breast Cancer Res 2:307-310
30. Cortesi L, Turchetti D, Bertoni C, et al (2000) Comparison between genotype and phenotype identifies a high-risk population carryng BRCA1 mutations. Genes Chromosomes Cancer 27:130-135
31. Turchetti D, Cortesi L, Federico M et al (2000) BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer. Eur J Cancer 36:2083-2089
32. Malone KE, Daling JR, Thompson JD et al (1998) BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before 45 years with first-degree family hystory. J Am Med Assoc 279:922-929
33. Capalbo C, Ricevuto E, Vestri A et al (2006) BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models. Ann Oncol; 17(7):vii34-vii40
34. Malander S, Ridderheim M, Masback A et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40:422-428
35. Johannesdottir G, Gudmundsson J, Bergthorsson JT et al (1996) High prevalence of the 999del5 mutation in Icelandic breast cancer patients. Cancer Res 56:3663-3665
36. Struewing JP, Coriaty ZM, Ron E et al (1999) Founder BRCA1/2mutations among male patients with breast cancer in Israel. Am J Hum Genet 65:1800-1802
37. Basham VM, Lipscombe JM, Ward JM et al (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4(1):R2
38. De La Hoya M, Osorio A, Godino J et al (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466-471
39. Ottini L, Masala G, D'Amico C et al (2003) BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 63:342-347
40. Iau PTC, M. Marafie A. Ali et al (2004) Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer. Breast Cancer Res Treatment 85:81-88
41. Crook T, Brooks LA, Crossland S et al (1998) P53 mutations with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2- associated breast tumours. Oncogene 17:1682-1689
42. Eisinger F, Jacquemier J, Charpin C et al (1998) Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res 58:1588-1592
43. Vezina H, Durocher F, Dumont M et al (2005) Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast-ovarian cancer families. Hum Genet 117:119-132
44. Muller D, Bonaiti-Pellie C, Abecassis J et al (2004) BRCA1 testing in breast ad/or ovarian cancer families from north-eastern France identifies two common mutations with a founder effect. Familial Cancer 3:15-20
45. Calo V, Agnese V, Gargano G et al (2005) A new germline mutation in a Sicilian family with ovarian cancer. Breast Cancer Res Treat 22:1-4
46. Morris JR, Pangon L, Boutell C et al (2006) Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Human Mol Genet 15(4):599-606
47. Fleming MA, Potter JD, Ramirez CJ et al (2003) Understanding missense mutations in the BRCA1 gene: An evolutionary approach. PNAS 100(3):1151-1156
48. Abkevich V, Zharkikh A, Deffenbaugh AM et al (2004) Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation. J Med Genet 41: 492-507
49. Augello C, Bruno L, Bazan V et al (2006) Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Ann Oncol 17(Suppl 7):vii30-vii33
50. Tavtigian SV, Deffenbaugh AM, Yin L et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43:295-305